Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
NCT06309225
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Oropharynx Cancer
Frailty
Interventions
RADIATION:
Modified dose and fields intensity modulated radiotherapy
Sponsor
Omar Mahmoud